DUPIXENT is the only dual inhibitor of IL-4 and IL-13 signaling. It is the only FDA-approved biologic indicated for OCS-dependent asthma patients. The mechanism of dupilumab action has not been definitively established.¹

WATCH A VIDEO ON THE UNIQUE MOA OF DUPIXENT